Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
about
Leishmania infection: laboratory diagnosing in the absence of a "gold standard".Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs.Serological and infection statuses of dogs from a visceral leishmaniasis-endemic area.Detection of anti-Leishmania immunoglobulin G antibodies in urine specimens of dogs with leishmaniasisEvaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogsSuccessful treatment of canine cutaneous leishmaniasis using radio-frequency induced heat (RFH) therapy.Immunologic progression of canine leishmaniosis following vertical transmission in United States dogs.Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.Comparison of a rapid immunochromatographic assay with an immunofluorescent antibody test for detection of Leishmania infantum antibodies in dogs.Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis.Relationship between Leishmania IFAT titer and clinicopathological manifestations (clinical score) in dogs.Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.Multi-antigen print immunoassay (MAPIA)-based evaluation of novel recombinant Leishmania infantum antigens for the serodiagnosis of canine visceral leishmaniasis.Assessment of the sensitivity and specificity of serological (IFAT) and molecular (direct-PCR) techniques for diagnosis of leishmaniasis in lagomorphs using a Bayesian approach.Further evidence associating IgG1, but not IgG2, with susceptibility to canine visceral leishmaniasis caused by Leishmania (L.) infantum chagasi-infection.A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.Clinical and immunopathological findings during long term follow-up in Leishmania infantum experimentally infected dogs.Proteinuria reduction after treatment with miltefosine and allopurinol in dogs naturally infected with leishmaniasis.Vaccines for canine leishmaniasisParasitic Infections in Humans and Animals
P2860
Q33617583-676B8D52-335A-4325-8BAB-6540B14A890BQ33817557-CF09F358-AB05-4890-9B95-E117F326B2DFQ34271852-9856BB41-2EFB-4362-B135-EAE196654732Q35215876-ECBBC8BF-40D8-4643-8548-98DD12B66860Q35702943-9B6D48D6-A5B5-4095-B6F1-18470AA0E540Q35783547-65702042-C07D-4BAC-A0AB-FF92157E8A3CQ36149610-27ECCF07-1B87-43A9-93DC-4B36261E0B9BQ36706960-6467668D-EE27-44EA-875E-0DF4B0C6A25AQ36945381-4F393D57-A9A1-4793-84DC-AC1CB73BB07CQ37229935-041A9EC9-91EF-4519-92D0-15AEB78DB945Q40409073-5A519C5B-5830-4442-8074-489AF002F3C2Q40469485-A9D72930-47BB-4101-B34B-9AAE9B4D0711Q40959769-B92E0563-CB40-4E4B-82DA-A9D698A6C47CQ41261778-E6A62A31-D07A-418A-9E88-FB137CD1FB84Q41524825-9A14724A-A921-446D-8E95-059772A5E9CAQ42682671-863C9658-B710-4FDF-B23A-46D829A7BB99Q42702134-D48FE900-83D2-4051-8CAD-E4327BF8F7CCQ43893585-0E6EB06F-F4CB-4CA5-A78E-41618FF8A98CQ44946324-5CBBEA36-FC01-4707-B436-CF4183D16B08Q47096541-340439BB-DB7D-439E-88C7-D79DE2701623Q54532412-2C548980-6233-4895-B3D1-C7747C20AD60Q56769198-BEB2743C-329B-4E27-BC9F-AA4ACA4F67E5Q58493528-D071C8C0-0A3F-40EB-9ECE-43FB127956F4
P2860
Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Leishmania infantum-specific I ...... infection and after treatment.
@en
Leishmania infantum-specific I ...... infection and after treatment.
@nl
type
label
Leishmania infantum-specific I ...... infection and after treatment.
@en
Leishmania infantum-specific I ...... infection and after treatment.
@nl
prefLabel
Leishmania infantum-specific I ...... infection and after treatment.
@en
Leishmania infantum-specific I ...... infection and after treatment.
@nl
P2093
P50
P1476
Leishmania infantum-specific I ...... infection and after treatment
@en
P2093
J E Valladares
L Solano-Gallego
S Castillejo
P304
P356
10.1016/S0304-4017(00)00446-5
P577
2001-04-01T00:00:00Z